These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3600053)

  • 1. Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil.
    Andersson BS; Beran M; Stuckey SE; McCredie KB; Mavligit GM
    Med Oncol Tumor Pharmacother; 1987; 4(1):17-21. PubMed ID: 3600053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo.
    Radel S; Bankusli I; Mayhew E; Rustum YM
    Cancer Chemother Pharmacol; 1988; 21(1):25-30. PubMed ID: 3342462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
    de Jong S; Zijlstra JG; de Vries EG; Mulder NH
    Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia.
    Keating MJ; Gehan EA; Smith TL; Estey EH; Walters RS; Kantarjian HM; McCredie KB; Freireich EJ
    J Clin Oncol; 1987 May; 5(5):710-21. PubMed ID: 3553435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.
    Zwelling LA; Mitchell MJ; Satitpunwaycha P; Mayes J; Altschuler E; Hinds M; Baguley BC
    Cancer Res; 1992 Jan; 52(1):209-17. PubMed ID: 1309224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
    Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
    Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
    Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil on uptake and in vitro toxicity of anthracyclines in human leukemic blast cells.
    Tidefelt U; Sundman-Engberg B; Paul C
    Eur J Haematol; 1988 May; 40(5):385-95. PubMed ID: 3163975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs in the treatment of acute and chronic leukemia with some emphasis on m-AMSA.
    Jehn U; Heinemann V
    Anticancer Res; 1991; 11(2):705-11. PubMed ID: 2064323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of nuclear m-AMSA content by DNA fluorochrome competition.
    Andersson BS; Beran M; Barlogie B; Van NT; McCredie KB
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):883-9. PubMed ID: 3464432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
    Odaimi M; Andersson BS; McCredie KB; Beran M
    Cancer Res; 1986 Jul; 46(7):3330-3. PubMed ID: 3754787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
    Snow K; Judd W
    Br J Cancer; 1991 Jan; 63(1):17-28. PubMed ID: 1989661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.
    Beran M; Andersson BS
    Cancer Res; 1987 Apr; 47(7):1897-904. PubMed ID: 3469023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
    Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.
    Zwelling LA; Mayes J; Hinds M; Chan D; Altschuler E; Carroll B; Parker E; Deisseroth K; Radcliffe A; Seligman M
    Biochemistry; 1991 Apr; 30(16):4048-55. PubMed ID: 1850298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amsacrine on ara-CTP cellular pharmacology in human leukemia cells during high-dose cytarabine therapy.
    Plunkett W; Nowak B; Keating MJ
    Cancer Treat Rep; 1987 May; 71(5):479-83. PubMed ID: 3567973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
    Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
    Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium influx blocker verapamil on adriamycin-induced cytotoxicity in leukemia cells in vitro.
    Mircheva JJ; Tsuruo T
    Acta Physiol Pharmacol Bulg; 1989; 15(4):3-8. PubMed ID: 2634901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the toxicity and antitumor activity of adriamycin-DNA and amsacrine-DNA complexes in mice].
    Zhang XG; Wu DZ
    Yao Xue Xue Bao; 1992; 27(11):801-5. PubMed ID: 1300022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.